Leerink Partnrs Estimates Genmab A/S Q3 Earnings
Genmab A/S (NASDAQ:GMAB – Free Report) – Research analysts at Leerink Partnrs issued their Q3 2025 EPS estimates for shares of Genmab A/S in a report issued on Thursday, February 13th. Leerink Partnrs analyst J. Chang forecasts that the company will earn $0.43 per share for the quarter. Leerink Partnrs has a “Strong-Buy” rating on […]
Genmab A/S (NASDAQ:GMAB – Free Report) – Research analysts at Leerink Partnrs issued their Q3 2025 EPS estimates for shares of Genmab A/S in a report issued on Thursday, February 13th. Leerink Partnrs analyst J. Chang forecasts that the company will earn $0.43 per share for the quarter. Leerink Partnrs has a “Strong-Buy” rating on […]
